YS Biopharma Co Ltd (YS)
0.9451
0.00 (0.00%)
USD |
NASDAQ |
May 20, 12:20
YS Biopharma Profit Margin (Quarterly): -108.4% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -108.4% |
| June 30, 2023 | -39.45% |
| Date | Value |
|---|---|
| September 30, 2022 | 4.36% |
| June 30, 2022 | -9.54% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-108.4%
Minimum
Sep 2023
4.36%
Maximum
Sep 2022
-38.26%
Average
-24.49%
Median
Profit Margin (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | -88.09% |
| Zai Lab Ltd | -61.36% |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -11.69% |
| Return on Invested Capital | -32.36% |
| Gross Profit Margin (Quarterly) | 81.92% |
| Operating Margin (Quarterly) | -103.3% |
| Return on Net Operating Assets | -12.52% |